ondasdechoque.org
PT-BR

Tendon mechanisms and translational research · Lab and clinical study · 2023

What do shockwaves do inside a tendon?

This review gathered lab and animal research on how shockwaves affect tendons. At some doses, cells, blood vessels and tendon tissue showed changes that may support repair. Higher doses sometimes harmed cells or tissue. It did not look at pain or function in patients.

Explores how shockwave works
studies reviewed
23
kinds of animals: rats, rabbits, horses, ponies, dogs
5
cell-culture studies
6

Good to know: Based on 23 lab and animal studies up to December 2021; responses varied by species, tendon and dose.

Poenaru D, Sandulescu MI, Cinteza D Biomedical Reports, 2023 · Read the paper ↗

The treatment

Review exposure scope
Focused and radial ESWT protocols varied by experimental model, tendon, energy-flux density, pulse count and schedule; no single patient protocol can be extracted.
Comparator
Study-specific contralateral-limb, untreated or laboratory comparison conditions; no pooled clinical comparator.

Who took part

No patients were treated: lab studies of tendon cells and tissue, including two studies of human tendon tissue, plus animal studies.

Side effects

In some lab and animal studies, higher doses reduced cell survival and caused tissue damage or inflammation. The review did not look at side effects in patients.

All the numbers and the full appraisal
FROM THE FULL PAPER

What the full paper reports.

The evidence spans animal tendon models, human tendon tissue studies and in-vitro cultures. The authors describe in-vivo work in rats, rabbits, horses, ponies and dogs, two human tissue studies, and six cell-culture papers. This is a heterogeneous evidence map, not a patient cohort.

Study-specific histology, cell viability, biochemical, vascular and biomechanical assessments1 reported outcome
01
Study-specific; from hours to weeks after exposure

Tendon biological and structural responses to ESWT

Study-specific histology, cell viability, biochemical, vascular and biomechanical assessments Qualitative synthesis

The review describes varied, dose-related responses across models. Some exposures accompanied cellular, vascular, matrix and biomechanical changes interpreted as potentially reparative; higher exposures also produced reduced viability or structural disruption in some models. The review does not quantify clinical pain or functional benefit.

Analysis details and source

Narrative synthesis of 23 records; animal and in-vitro results are not patient outcomes. Studies with quantitative pain/function assessments were excluded.

How treatment was delivered
Review exposure scope

Focused and radial ESWT protocols varied by experimental model, tendon, energy-flux density, pulse count and schedule; no single patient protocol can be extracted.

Comparator

Study-specific contralateral-limb, untreated or laboratory comparison conditions; no pooled clinical comparator.

HARMS & TOLERABILITY

Some experimental models showed dose-related cell-viability reduction and tissue changes including collagen disorganization, necrosis or inflammatory reactions. The review does not estimate clinical adverse events.

LIMITS OF THE ANALYSIS

The evidence combines species, tendon sites, tissue states, exposure settings and experimental methods. In-vitro and animal findings cannot be assumed to predict patient outcomes. Search was limited to PubMed and Cochrane, to full texts available at the authors' institution, and to studies available through December 2021; quantitative pain/function studies were excluded.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • The evidence combines species, tendon sites, tissue states, exposure settings and experimental methods. In-vitro and animal findings cannot be assumed to predict patient outcomes. Search was limited to PubMed and Cochrane, to full texts available at the authors' institution, and to studies available through December 2021; quantitative pain/function studies were excluded.
Research review

Source-linked critical reading

Systematic mechanistic review with human, animal and laboratory components

Reading depthMaterial consulted
Technical source record

Full-text XML read from Introduction through disclosures. Reviewed study selection, Table I, all mechanistic results, discussion, both figure captions and end-matter. Supplementary material was not identified.

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Design and evidence base

Systematic mechanistic review of 23 full-text records selected from 7,120 titles identified in PubMed and Cochrane searches through December 2021. Quantitative pain and function studies were excluded.

Evidence base

The evidence spans animal tendon models, human tendon tissue studies and in-vitro cultures. The authors describe in-vivo work in rats, rabbits, horses, ponies and dogs, two human tissue studies, and six cell-culture papers. This is a heterogeneous evidence map, not a patient cohort.

Exposure protocols

The review covers focused and radial ESWT exposures with different energy-flux densities, pulse counts and schedules. Protocols vary by species, tendon, normal versus diseased tissue, and laboratory versus living-tissue model; the review does not establish a transferable clinical regimen.

Experimental comparators

Many in-vivo experiments used the contralateral limb as control; cell and tissue studies used study-specific untreated or comparison conditions. These are not a single comparator or pooled patient-treatment contrast.

Biological outcomes

The review synthesizes viability, angiogenesis, cellular activity, extracellular-matrix turnover, inflammatory mediators and biomechanical properties qualitatively. It explicitly excluded quantitative pain and function outcomes.

Synthesis of findings

Across models, the authors describe dose-related biological responses, with potentially regenerative changes at some exposures and reduced cell viability or structural disruption at higher exposures. Responses varied by species and tendon. These mechanistic observations do not estimate clinical benefit.

Potential tissue harms

Structural damage, collagen disorganization, inflammatory reaction and reduced cell viability were reported in some experimental models at higher exposures. The review does not provide a patient-level adverse-event estimate; absence of such an estimate is not evidence of zero clinical harms.

Limitations

The evidence combines species, tendon sites, tissue states, exposure settings and experimental methods. In-vitro and animal findings cannot be assumed to predict patient outcomes. Search was limited to PubMed and Cochrane, to full texts available at the authors' institution, and to studies available through December 2021; quantitative pain/function studies were excluded.

Applicability

This review supports biological plausibility and highlights dose- and tissue-specific responses. It cannot tell patients how likely pain relief or functional recovery is, identify an optimal clinical dose, or establish comparative effectiveness.

Research needs

Clinical studies should prespecify diagnosis-specific protocols and patient-important outcomes, while translational experiments should report species, tendon, tissue state, device parameters, controls and timing in enough detail to test dose-response without treating one model as universal.

THE ORIGINAL SOURCE

Read the original article.

Biological effects of extracorporeal shockwave therapy in tendons: A systematic review.

Poenaru D, Sandulescu MI, Cinteza D. · Biomedical reports · 2023

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →